CapyBio
2 known investors
CapyBio provides a computational platform for measuring cell identity and predicting cell fate transitions, serving researchers and developers in cell therapy, regenerative medicine, and pre-clinical testing. The platform combines measurement tools (Capybara), prediction algorithms (CellOracle), and wet lab integration to enable iterative cell engineering.